Amgen's MariTide Weight Loss Potential: Stock Outlook

Amgen TodayAMGNAmgen$313.39 -15.56 (-4.73%) 52-Week Range$248.38▼$346.85Dividend Yield2.87%P/E Ratio44.77Price Target$312.63Add to WatchlistAmgen NASDAQ: AMGN is a biotechnology firm that has made its way into the weight loss treatment battle. The company’s shares have performed relatively well in 2024, providing a total return of 16%, outpacing its sector and the market. The Health Care Select Sector SPDR Fund NYSEARCA: XLV has returned 9%.Let's start by exploring Amgen's main products and growth opportuni ...